| Literature DB >> 31651345 |
Lufeng Zheng1, Qianqian Guo1, Chenxi Xiang2, Shijia Liu3, Yuzhang Jiang4, Lanlan Gao1, Haiwei Ni1, Ting Wang1, Qiong Zhao1, Hai Liu1, Yingying Xing1, Yaohui Wang5, Xiaoman Li6, Tao Xi7.
Abstract
The original article [1] contained an error in Fig. 7c whereby the same flow image was accidentally misused for the second and fourth group.Entities:
Year: 2019 PMID: 31651345 PMCID: PMC6814126 DOI: 10.1186/s13045-019-0809-3
Source DB: PubMed Journal: J Hematol Oncol ISSN: 1756-8722 Impact factor: 17.388
Fig. 7CeRNET_CC is sufficient and necessary for six2-induced effects. a, b Phase contrast images of mammospheres formed by MCF-7-six2 cells with si-CYP4Z1 or si-CYP4Z2P treatment (a) and quantification of spheres (b). The data are presented as the means ± SDs, n = 3, *P < 0.05, **P < 0.01 vs. MCF-7-six2. c Representative FACS profile of cells described in a with CD24− and CD44+ markers. d, e Cells depicted in a were subjected to western blot analysis and followed by detecting the expression of p-Akt/p-ERK1/2 (e) and stemness markers (ALDH1 and OCT3/4) (d). f Images of tumors harvested when MCF-7, MCF-7-six2, MCF-7-six2-si-Z1, and MCF-7-six2-si-Z2P cells (left) and MCF-7-Plko-six2, MCF-7-Plko-six2-Z1-UTR, and MCF-7-Plko-six2-Z2P-UTR cells (right) were planted